Hydrogel Delivery Device for the In Vitro and In Vivo Sustained Release of Active rhGALNS Enzyme

• Váldodahkkit: Michael Flanagan (Dahkki), Qi Gan (Dahkki), Saahil Sheth (Dahkki), Rachel Schafer (Dahkki), Samuel Ruesing (Dahkki), Linda E. Winter (Dahkki), Karoly Toth (Dahkki), Silviya P. Zustiak (Dahkki), Adriana M. Montaño (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: MDPI AG, 2023-06-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Morquio A disease is a genetic disorder resulting in N-acetylgalactosamine-6-sulfate sulfatase (GALNS) deficiency, and patients are currently treated with enzyme replacement therapy via weekly intravenous enzyme infusions. A means of sustained enzyme delivery could improve patient quality of life by...